Clearstead Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Clearstead Advisors's NUVB Position: Q3 2026 in Review
Clearstead Advisors reduced its Nuvation Bio (NUVB) stake by 69% in Q3 2026, selling an estimated $734 and leaving 52 shares worth $292. The position accounts for ﹤0.01% of the portfolio, ranked #3015.
Clearstead Advisors first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.57K in Q3 2025. 259 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Clearstead Advisors held 52 shares of Nuvation Bio worth $292 as of Q3 2026.
- Clearstead Advisors sold 117 Nuvation Bio shares in Q3 2026, an estimated $734.
- Nuvation Bio made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #3015 holding.
- Clearstead Advisors first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
- Clearstead Advisors's Nuvation Bio position peaked at $4.57K in Q3 2025.
- 259 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.